3579 results for «327»
3579 results
The year in review in Interventional Cardiology: clinical trials and relevant literature published in 2020
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to reflect on key learnings for clinical practice from selected trials published in 2020, to get a rapid overview of the most relevant literature of the year in the fields of coronary, valvular and peripheral interventions and to see examples...
PCR Valves e-Course 2020 best TAVI cases - session I
22 Nov 2020 – From PCR Valves e-Course 2020
- Hybrid coronary protection in ViV TAVI with BASILICA and chimney techniques. M. Pighi, Italy
- Transcatheter closure of a LV pseudoaneurysm after transapical ViV TAVI. E. Garau, Italy
- Anterograde crossing of a bicuspid aortic valve to facilitate TAVI. B. Bawamia, United Kingdom
- Coronary protection with BASILICA technique and IVUS, followed...
PCR Valves e-Course 2020 best innovations
24 Nov 2020 – From PCR Valves e-Course 2020
- Treatment of MR: physiological annulus downsizing with an innovative helix ring. Long-term results with surgical model and mid-term results with transcatheter model. K. Kervinen, Finland
- First-in-man experience with a single-piece, durable aortic valve therapy. B. Meuris, Belgium
- First-in-man experience of CroíValve Duo a novel percutaneous transcatheter tricuspid coaptation...
Multi-modality imaging for transcatheter tricuspid valve interventions
23 Nov 2020 – From PCR Valves e-Course 2020
Watch this session if you want to appreciate how cardiac chamber views can be used to create a common language across imaging modalities and to understand the relationship between cardiac chamber views and optimal projection curves (S-curves).
This session was originally presented during PCR Valves e-Course 2020.
Multi-modality imaging for transcatheter aortic valve interventions (TAVI)
24 Nov 2020 – From PCR Valves e-Course 2020
Watch this session if you want to understand the relationship between cardiac chamber views and optimal projection curves (S-curves) and to learn how to apply cardiac chamber views and S-curves in transcatheter aortic valve interventions (TAVI / TAVR)
Evidence counts: latest data from Onyx one-month DAPT programme and renal denervation
12 Dec 2020 – From GulfPCR-GIM 2020
In this session you will get an overview of the subanalysis of Onyx One-month DAPT program which evaluated highly complex high-bleeding risk patients on one-month DAPT, followed by the latest evidence on renal denervation for the treatment of hypertension.
Robotic PCI and advancements in smart procedural automation
12 Dec 2020 – From GulfPCR-GIM 2020
A. Nooryani talks with J. Fajadet about the beginnings of robotic procedures in interventional cardiology in the United Arab Emirates and shares his experience using this new technology, demonstrating with cases.
Latest evidence on cardiogenic shock management
13 Dec 2020 – From AICT-AsiaPCR 2020
Find out more about the latest evidence on the management of cardiogenic shock followed by key messages to improve the outcome of very sick cardiogenic shock patients.
The future of hypertension management: another treatment option
13 Dec 2020 – From AICT-AsiaPCR 2020
Join A. Fong and Y-H. Lee as they share their experience on the management of hypertension and the latest information on renal denervation.
What you need to know about DAPT in high-bleeding risk patients
12 Dec 2020 – From GulfPCR-GIM 2020
This educational session focuses on the high-bleeding risk situation in the Gulf Region, the latest evidence on HBR and how to integrate it into your practice, followed by challenging cases discussed by Mirvat Alasnag,Thomas Cuisset, Marco Valgimigli and Peter Smits.
Advancement in bifurcation and renal denervation – The right procedure for the right patient?
13 Dec 2020 – From AICT-AsiaPCR 2020
Watch this session to learn more about how and when to select DK crush technique or provisional stenting in bifurcation cases, the pros and cons of both techniques, as well as patient selection for renal denervation in the treatment of uncontrolled hypertension.
PCR Valves e-Course 2020 Hotline - ACTIVATION trial, NIUT in patients with severe symptomatic calcific aortic stenosis, CUTTING-EDGE registry...
22 Nov 2020 – From PCR Valves e-Course 2020
- The percutAneous Coronary inTervention prIor to trans-catheter aortic VAlve implantaTION trial. S. Redwood: ACTIVATION Trial. S. Redwood
- Prospective, single-arm clinical investigation for the safety and feasibility study of Valvosoft NIUT in patients with severe symptomatic calcific aortic stenosis - First-in-man. E. Messas
- Outcomes of mitral valve surgery after...
Mastering tricuspid TEER - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
A 77-year-old male with atrial fibrillation and chronic kidney disease presented with symptomatic severe atrial tricuspid regurgitation.He underwent implantation of two TriClip XTW devices (antero-septal and postero-septal) under general anesthesia, guided by transesophageal echocardiography (TEE).
LIVE Educational Case from Bordeaux University Hospital - Bordeaux, France
Navigate the video...
Expanding horizons with balloon-expandable TAVI - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Meril Life
A 76-year-old male with a history of abdominal and iliac stent grafts (2022), severe COPD, prostate cancer, and gastric ulcer presented with symptomatic severe aortic stenosis. CT and echocardiography showed a calcified bicuspid aortic valve with preserved LV...
Redefining and optimising LAA closure - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Boston Scientific
A 78-year-old woman with atrial fibrillation and obesity (BMI 34.3), normal left ventricular function, CHADS-VASCs 5 and HAS-BLED 4, presented with severe gastrointestinal bleeding.
She underwent implantation of a Watchman FLX™ pro under local anesthesia via two right femoral...
Tailored transfemoral TAVI in complex anatomies - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Medtronic
An 89-year-old male with hypertension, dyslipidemia, current smoking, stage III kidney disease, and a history of diagonal PCI in 2010 presented with severe symptomatic aortic stenosis and a small annulus (410 mm²), with RBBB on ECG.
Via bilateral femoral access,...
COMPARE CRUSH: A randomized trial of prehospital crushed vs uncrushed prasugrel in STEMI
20 Oct 2020
Luis Ortega-Paz provides a summary of the key messages from the COMPARE CRUSH trial. He also discusses the main findings and recommendations in clinical practice with Georgios Vlachojannis who presented the results during TCT Connect 2020.
Author
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis
07 Nov 2021
Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.
Author
Summary and take home messages of the late-breaking clinical trials presented during #TCTConnect 2020
19 Oct 2020
Vijay Kunadian provides a summary of the coronary & structural late-breaking studies presented during TCT Connect 2020 and shares some take-home messages. See how these studies might influence your daily practice!
Author
